A carregar...

Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta

We report a direct comparison of RANKL inhibition (RANK-Fc) with bisphosphonate treatment (ALN) from infancy through early adulthood in a mouse model of Osteogenesis Imperfecta. Both ALN and RANK-Fc decreased fracture incidence to the same degree with increases in metaphyseal bone volume via increas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bargman, R, Posham, R, Boskey, AL, DiCarlo, E, Raggio, C, Pleshko, N
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3922057/
https://ncbi.nlm.nih.gov/pubmed/21901481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00198-011-1742-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!